SRTA STRATA CRITICAL MEDICAL, INC.
Research report · from SEC EDGAR · close 2026-07-13
$5.01 -2.0%
$433.5M mkt cap
executive summary
STRATA CRITICAL MEDICAL, INC. (SRTA) is a $433.5M company. Revenue is $197.1M (+34.3% y/y) at a 21% net margin. It is profitable. Our health score is C (63/100). 2 red flags on file. Held by 1 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$197.1M
+34.3% y/y
⚠Earnings-manipulation risk
Beneish M-Score (0.05) is above the threshold — a screen for earnings-quality review, not an accusation (fast growers can trip it).
⚠One-sided insider selling
6 insider sales and no open-market buys in the recent window.
who's buying
Insider buys / sells
0 / 6
Cash & ST investments
$58.7M
Operating cash flow
-$48.9M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.